Fabien Guillemot will take part in the European Commission’s Joint Research Centre workshop in Brussels “Towards Standards in Biomedicine”
We’re excited to announce that Poietis Biosystems has been selected by Bordeaux Métropole to join the delegation of innovative healthtech companies representing our regional ecosystem at the CHU Healthtech Connexion Day 2025, taking place on December 8–9 at the Palais des Congrès in Bordeaux.
This event brings together clinicians, researchers, industry leaders, and innovators to explore the future of healthcare across AI & data, precision medicine, therapeutic innovations, and the hospital of the future.
🔬 Poietis will be there with our bioprinting system — and we’ll be running live demos throughout the event.
Participants will have the opportunity to discover how our next-generation, laser-assisted bioprinting and AI-driven process control support high-precision biofabrication and the development of advanced tissue models.
Being selected as one of the 20 companies to represent local innovation is a strong recognition of:
- the maturity of our technology
- our commitment to shaping the future of bioprinting
- and our deep involvement in the regional health innovation ecosystem
We look forward to meeting healthcare professionals, partners and fellow innovators, and to sharing how bioprinting can support the transition toward more personalized and regenerative medicine.
If you’re attending, come meet us and experience bioprinting live!
Official website for this event : https://www.chu-healthtech-cday.com/
#Poietis #PoietisBiosystems #Bioprinting #Biofabrication #HealthTech #Innovation #RegenerativeMedicine
Projected use on NGB
The same laser-assisted process runs on the NGB-R® research platform and continues on the GMP-grade NGB-C® for clinical translation. Map this to your own model →
